STRUCTURE, FUNCTION, AND MODULATION OF SERORTONIN (3A) RECEPTORS
5-羟色胺 (3A) 受体的结构、功能和调节
基本信息
- 批准号:9898063
- 负责人:
- 金额:$ 7.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:BiochemicalBipolar DepressionBipolar DisorderCancer EtiologyClinicalComplementCryoelectron MicroscopyDevelopmentDiarrheaDrug DesignDrug TargetingElectrophysiology (science)EnvironmentEventFoundationsGated Ion ChannelGoalsInfectionIon Channel GatingIrritable Bowel SyndromeLengthLigandsLipidsMembraneMembrane LipidsMolecularMolecular ConformationMood DisordersNausea and VomitingNeurologicPainPhysiologic pulsePhysiologicalPlayProcessProteinsResolutionRestRoleSerotoninSignal TransductionStructureTherapeuticTreatment EfficacyWorkcancer therapygastrointestinalgastrointestinal functioninhibitor/antagonistinterdisciplinary approachpain perceptionparticlereceptorserotonin receptortransmission process
项目摘要
Project Summary/Abstract
The overarching goal of this proposal is to determine the structural basis for allosteric mechanisms governing
gating and modulation in serotonin receptors (5-HT3AR). 5-HT3ARs play a crucial role in gastrointestinal
functions, pain transmission, and mood disorders. Inhibitors of 5-HT3AR are in the clinical use to alleviate nausea
and vomiting caused by cancer therapies, manage post-infection diarrhea and irritable bowel syndrome, and
treat neurological conditions such as bipolar disorder and depression. Rational drug design has been limited by
poor understanding of the structure-function correlations in 5-HT3AR and the downstream signaling events. We
recently solved the structure of the full-length 5-HT3AR in the resting conformation by single-particle cryo-
electron microscopy (cryo-EM). By capitalizing on this technical advancement and further biochemical
optimization, we aim to determine the conformational changes underlying 5-HT3AR gating and lipid modulation.
We will achieve these goals by a combination of multidisciplinary approaches that include cryo-EM, pulsed-
EPR, and electrophysiology. Specifically, we will determine high-resolution snapshots of 5-HT3AR in multiple
functional states, in modulator-bound conformations, and in the presence of membrane lipid constituents. These
structures will be complemented with protein dynamic studies in a membrane environment and extensive
functional analysis. Our proposed work is expected to provide structural blueprints of the channel in
physiologically relevant conformations and unravel the molecular mechanisms underlying channel function.
These studies will be foundational in the targeted drug design for safer and effective therapeutics.
项目总结/摘要
该提案的总体目标是确定变构机制的结构基础,
5-羟色胺受体(5-HT 3AR)的门控和调节。5-HT 3ARs在胃肠道疾病中起着至关重要的作用。
功能、疼痛传递和情绪障碍。5-HT 3AR抑制剂在临床上用于缓解恶心
和呕吐引起的癌症治疗,管理感染后腹泻和肠易激综合征,
治疗神经系统疾病,如双相情感障碍和抑郁症。合理的药物设计受到以下因素的限制
对5-HT 3AR和下游信号事件的结构-功能相关性的理解不足。我们
最近通过单粒子冷冻技术解决了静息构象中全长5-HT 3AR的结构,
电子显微镜(cryo-EM)。通过利用这一技术进步和进一步的生物化学
通过优化,我们的目的是确定潜在的5-HT 3AR门控和脂质调节的构象变化。
我们将通过多学科方法的组合来实现这些目标,包括冷冻EM,脉冲-
EPR和电生理学。具体来说,我们将在多个实验中确定5-HT 3AR的高分辨率快照。
功能状态,在调制器结合构象,并在膜脂质成分的存在下。这些
结构将补充蛋白质动态研究在膜环境和广泛的
功能分析我们提出的工作预计将提供渠道的结构蓝图,
生理相关的构象和解开通道功能的分子机制。
这些研究将为更安全有效的靶向药物设计奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sudha Chakrapani其他文献
Sudha Chakrapani的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sudha Chakrapani', 18)}}的其他基金
Acquisition of 200kV Glacios Cryo Transmission Electron Microscope
购置 200kV Glacios 冷冻透射电子显微镜
- 批准号:
10430469 - 财政年份:2022
- 资助金额:
$ 7.16万 - 项目类别:
Structure and Function of Pentameric Ligand-Gated Ion Channels
五聚体配体门控离子通道的结构和功能
- 批准号:
10317065 - 财政年份:2020
- 资助金额:
$ 7.16万 - 项目类别:
Structure and Function of Pentameric Ligand-Gated Ion Channels
五聚体配体门控离子通道的结构和功能
- 批准号:
10388455 - 财政年份:2020
- 资助金额:
$ 7.16万 - 项目类别:
Structure and Function of Pentameric Ligand-Gated Ion Channels
五聚体配体门控离子通道的结构和功能
- 批准号:
10797535 - 财政年份:2020
- 资助金额:
$ 7.16万 - 项目类别:
Structure and Function of Pentameric Ligand-Gated Ion Channels
五聚体配体门控离子通道的结构和功能
- 批准号:
10543499 - 财政年份:2020
- 资助金额:
$ 7.16万 - 项目类别:
Pulsed-Electron Paramagnetic Resonance Spectrometer for Distance Determination in Biological Macromolecules
用于生物大分子距离测定的脉冲电子顺磁共振波谱仪
- 批准号:
9492211 - 财政年份:2018
- 资助金额:
$ 7.16万 - 项目类别:
Molecular Mechanisms of Desensitization and Drug Modulation in Ligand-Gated Ion C
配体门控离子 C 脱敏和药物调节的分子机制
- 批准号:
8916155 - 财政年份:2014
- 资助金额:
$ 7.16万 - 项目类别:
Molecular Mechanisms of Desensitization and Drug Modulation in Ligand-Gated Ion Channels
配体门控离子通道脱敏和药物调节的分子机制
- 批准号:
9291772 - 财政年份:2014
- 资助金额:
$ 7.16万 - 项目类别:
Molecular Mechanisms of Desensitization and Drug Modulation in Ligand-Gated Ion C
配体门控离子 C 脱敏和药物调节的分子机制
- 批准号:
8757924 - 财政年份:2014
- 资助金额:
$ 7.16万 - 项目类别:
相似海外基金
Psilocybin Assisted Psychotherapy for Bipolar Depression: An fMRI Emotional-Processing Pilot Study
裸盖菇素辅助双相抑郁心理治疗:功能磁共振成像情绪处理试点研究
- 批准号:
486939 - 财政年份:2023
- 资助金额:
$ 7.16万 - 项目类别:
Miscellaneous Programs
Repeated Ketamine Infusions for Cognitive Impairment in Treatment-Resistant Bipolar Depression
反复输注氯胺酮治疗难治性双相抑郁症的认知障碍
- 批准号:
486443 - 财政年份:2022
- 资助金额:
$ 7.16万 - 项目类别:
Studentship Programs
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study
裸盖菇素对治疗难治性双相抑郁症的神经生物学作用:情绪处理功能磁共振成像初步研究
- 批准号:
486577 - 财政年份:2022
- 资助金额:
$ 7.16万 - 项目类别:
Studentship Programs
Reward and stress: Developing neuroimaging biomarkers for bipolar depression
奖励和压力:开发双相抑郁症的神经影像生物标志物
- 批准号:
2748645 - 财政年份:2022
- 资助金额:
$ 7.16万 - 项目类别:
Studentship
Theta-burst stimulation for bipolar depression: A randomized controlled trial
θ 爆发刺激治疗双相抑郁症:一项随机对照试验
- 批准号:
469571 - 财政年份:2022
- 资助金额:
$ 7.16万 - 项目类别:
Operating Grants
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind Placebo Controlled Trial
大麻二酚辅助治疗急性双相抑郁症:随机双盲安慰剂对照试验
- 批准号:
444068 - 财政年份:2021
- 资助金额:
$ 7.16万 - 项目类别:
Operating Grants
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized, Midazolam-Controlled Phase II Clinical Trial
重复氯胺酮输注治疗难治性双相抑郁症:一项随机、咪达唑仑对照的 II 期临床试验
- 批准号:
434675 - 财政年份:2020
- 资助金额:
$ 7.16万 - 项目类别:
Operating Grants
Next Generation Drugs for Bipolar Depression and Maintenance
治疗双相抑郁症和维持治疗的下一代药物
- 批准号:
9555300 - 财政年份:2018
- 资助金额:
$ 7.16万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10080262 - 财政年份:2018
- 资助金额:
$ 7.16万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10588254 - 财政年份:2018
- 资助金额:
$ 7.16万 - 项目类别: